Drug Channels Archive for December, 2022

Click a link below to view the mailing archive as if it had been sent to you.

2022-12-20 07:47		Drug Channels News Roundup, December 2022: Vertical Integration Updated, Walgreens vs. Pharmacy, Cash-Pay Rx, Curing 340B, and Deductible Season
2022-12-19 07:47		Drug Channels - Value-Based Care Summit
2022-12-16 07:47		Drug Channels - The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money (rerun)
2022-12-15 07:47		Drug Channels - Five Surprising Facts About GoodRx and the Discount Card Market (rerun)
2022-12-14 07:47		Drug Channels - The Shady Business of Specialty Carve-Outs, a.k.a., Alternative Funding Programs (rerun)
2022-12-13 07:47		Drug Channels - Texas Shows Us Where PBMs' Rebates Go (rerun)
2022-12-12 07:47		Drug Channels - The Inflation Reduction Act: Three Unintended Consequences for Biosimilars, Health Plans, Providers, and Pharmacies (rerun)
2022-12-09 07:47		Drug Channels - Health Insurance Startup CEOs' Sky-High Compensation Figures Are Deceiving
2022-12-08 07:47		Join me next Friday for the Drug Channels Outlook 2023
2022-12-07 07:47		Drug Channels - Small Pharmacies Walk Away from Medicare Part D's 2023 Preferred Networks
2022-12-06 07:47		Drug Channels - CVS, Walgreens, and Walmart Keep Position in 2023 Part D Preferred Networks—While the Kroger Bails Over its Express Scripts Blowup
2022-12-02 07:47		Drug Channels - Developing a Channel Strategy that Optimizes Gross-to-Net